$137 Million is the total value of Birchview Capital, LP's 64 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $56,039,000 | +1.8% | 727,785 | -3.5% | 40.76% | +2.8% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $8,309,000 | -0.7% | 85,240 | -4.5% | 6.04% | +0.3% |
| FHTX | Sell | FOGHORN THERAPEUTICS INC | $3,874,000 | -13.5% | 284,843 | -3.2% | 2.82% | -12.6% |
| UTHR | Sell | UNITED THERAPEUTICS CORP | $3,535,000 | +9.5% | 15,000 | -16.7% | 2.57% | +10.6% |
| IMGN | Sell | IMMUNOGEN INC | $675,000 | -25.3% | 150,000 | -21.1% | 0.49% | -24.6% |
| AWH | Sell | ASPIRA WOMEN'S HEALTH INC | $49,000 | -54.2% | 83,104 | -19.4% | 0.04% | -53.2% |
| BIIB | Sell | BIOGEN INC | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| AKBA | Sell | AKEBIA THERAPEUTICS INC | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACCELERATE DIAGNOSTICS INC | 36 | Q3 2023 | 34.6% |
| QUIDELORTHO CORP | 36 | Q3 2023 | 8.6% |
| MASIMO CORP | 36 | Q3 2023 | 2.2% |
| PIONEER NATURAL RESOURCES CO (PXD) | 36 | Q3 2023 | 0.7% |
| XENCOR INC | 35 | Q3 2023 | 0.4% |
| NEUROCRINE BIOSCIENCES INC | 33 | Q3 2023 | 7.4% |
| CORCEPT THERAPEUTICS INC | 32 | Q3 2023 | 1.2% |
| BIOGEN INC | 31 | Q2 2022 | 3.1% |
| CONTRAFECT CORP | 30 | Q3 2022 | 1.6% |
| YIELD10 BIOSCIENCE INC | 26 | Q3 2023 | 0.6% |
View Birchview Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SOLENO THERAPEUTICS INC | March 19, 2019 | 742,635 | 2.3% |
| YIELD10 BIOSCIENCE, INC. | December 29, 2017 | 186,079 | 2.2% |
| HANSEN MEDICAL INC | February 16, 2016 | ? | ? |
| METABOLIX, INC. | June 23, 2015 | 749,696 | 2.8% |
View Birchview Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3/A | 2024-02-20 |
| 4/A | 2024-02-20 |
| SC 13G/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-04-07 |
| 4 | 2023-03-27 |
| 3 | 2023-02-13 |
View Birchview Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.